Calcium Channel Blocker Toxicity & Vasoplegic Shock
Emergency resuscitation of calcium channel blocker (CCB) overdoses: distinguishing verapamil/diltiazem cardiogenic collapse from amlodipine/nifedipine refractory vasoplegic shock, hyperglycemia as a hallmark of beta-islet inhibition, High-Dose Insulin Euglycemia (HIET), IV calcium chloride/gluconate, norepinephrine/epinephrine inotropes, methylene blue for nitric oxide synthase inhibition, and whole bowel irrigation for extended-release formulations.
Resuscitation Quick Actions • First 2 Minutes
IV Calcium Salts
Calcium Chloride 10% 1–2g (10–20 mL) IV central line OR Calcium Gluconate 10% 3–6g (30–60 mL) peripheral IV over 5–10 min; repeat q10–15 min x 3
HIET Protocol
Regular Insulin 1 unit/kg IV bolus + 1 unit/kg/hr infusion; titrate up to 5–10 units/kg/hr along with D10W/D20W for euglycemia
First-Line Vasopressors
Norepinephrine 0.05–0.5 mcg/kg/min + Epinephrine 0.05–0.5 mcg/kg/min for combined alpha-vasoconstriction and beta-inotropy
Methylene Blue (Vasoplegia)
1.5–2.0 mg/kg IV over 20–60 min for nitric-oxide mediated refractory vasoplegic vasodilatory shock
Whole Bowel Irrigation (WBI)
Polyethylene glycol (GoLYTELY) 1.5–2.0 L/hr via NG tube for massive sustained-release (SR/XL) ingestions presenting < 4–6 hours
Hyperglycemia Correlation
Blood glucose > 200–300 mg/dL without known diabetes indicates severe L-type calcium channel inhibition in pancreatic beta cells
Bottom-Line Clinical Pearl
Calcium channel blocker overdose is the most lethal prescription cardiovascular toxicity. Non-dihydropyridines (verapamil, diltiazem) cause profound myocardial depression, sinus bradycardia, and high-grade AV block. Dihydropyridines (amlodipine, nifedipine) produce catastrophic peripheral vasoplegic shock with reflex tachycardia initially. Hyperglycemia correlates directly with toxicity severity due to blockade of calcium-mediated insulin exocytosis from pancreatic beta-islet cells. Initiate aggressive IV calcium and early HIET (1–10 units/kg/hr); add norepinephrine/epinephrine and methylene blue for vasoplegia.
Calcium channel blockers antagonize voltage-gated L-type calcium channels in the heart, peripheral vascular smooth muscle, and pancreatic beta-islet cells. In overdose, receptor selectivity is lost, but primary clinical phenotypes differ significantly:
| Class & Agents | Primary Site of Action | Clinical Features in Overdose | Hemodynamic Profile |
|---|---|---|---|
| Non-Dihydropyridines (Verapamil, Diltiazem) | Myocardium & SA/AV Nodal Conduction Tissue | Severe sinus bradycardia, PR prolongation, complete heart block, junctional escape, profound myocardial depression, acute pulmonary edema | Cardiogenic Shock: Low Cardiac Output, Elevated SVR or Low SVR, High CVP |
| Dihydropyridines (Amlodipine, Nifedipine, Nicardipine) | Peripheral Vascular Arteriolar Smooth Muscle | Massive systemic arteriolar vasodilation, warm extremities, reflex tachycardia initially followed by terminal bradycardia as selectivity is lost | Vasoplegic/Distributive Shock: High/Normal Cardiac Output, Extremely Low SVR |
Endogenous insulin secretion by pancreatic beta cells is an active calcium-dependent exocytic process triggered by calcium influx through L-type channels. In significant CCB overdose, beta-cell channel blockade arrests insulin secretion, producing marked hyperglycemia (often 250–500+ mg/dL). In clinical trials, the magnitude of initial hyperglycemia correlates directly with the degree of shock, need for vasopressors, and in-hospital mortality.
| Step | Therapeutic Intervention | Dose & Administration Pearl |
|---|---|---|
| 1. Volume Resuscitation | Balanced Crystalloids (Plasmalyte or LR) | 1–2 L bolus; avoid over-resuscitation because impaired inotropy predisposes to iatrogenic pulmonary edema. |
| 2. Intravenous Calcium | Calcium Chloride 10% 1–2g IV central OR Calcium Gluconate 10% 3–6g IV peripheral | Administer over 5–10 min; repeat every 10–15 min up to 3–4 doses, then initiate continuous infusion (0.2–0.4 mL/kg/hr of 10% CaCl2). |
| 3. Early HIET | Regular Insulin 1 unit/kg IV bolus + 1 unit/kg/hr infusion | Titrate aggressively up to 5–10 units/kg/hr. Administer supplemental D10W/D20W only as needed to maintain euglycemia (100–200 mg/dL). |
| 4. Vasoactive Inotropes | Norepinephrine + Epinephrine infusions | Start norepinephrine 0.1–0.5 mcg/kg/min for vasoconstriction; add epinephrine 0.05–0.5 mcg/kg/min for chronotropic and inotropic support. |
| 5. Vasoplegia Rescue | Methylene Blue 1.5–2.0 mg/kg IV over 20 min | Inhibits inducible nitric oxide synthase (iNOS) and soluble guanylyl cyclase; reverses amlodipine-induced vascular smooth muscle paralysis. |
| 6. Decontamination | Whole Bowel Irrigation (WBI) | Indicated for confirmed large ingestions of sustained-release (ER/SR/XL) formulations presenting within 4–6 hours with a protected airway. |
Critical Pitfall / Contraindication
BEWARE EXTENDED-RELEASE AMITRIPTYLINE & AMLODIPINE DELAYS: Extended-release amlodipine, verapamil SR, and diltiazem CD ingestions may present completely asymptomatic with normal vitals for 6 to 12 hours post-ingestion before crashing into catastrophic refractory vasoplegia. Every patient with suspected extended-release CCB ingestion requires at least 24 hours of intensive cardiac monitoring.
Test Your Calcium Channel Blocker Toxicity & Vasoplegic Shock Clinical Acumen
Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.
Related Emergency Protocols & Differentials
Beta-Blocker Toxicity & High-Dose Insulin (HIET)
Management of beta-blocker overdose and HIET protocols.
Open Protocol Related EM ProtocolShock Classification & Undifferentiated Hypotension
Emergency evaluation of cardiogenic, distributive, and vasoplegic shock.
Open Protocol Related EM ProtocolCardiovascular Drug Toxicities & Salicylates
Core toxicology for cardiovascular medications.
Open Protocol